IDEAS home Printed from https://ideas.repec.org/a/gam/jmathe/v11y2023i13p3019-d1188780.html
   My bibliography  Save this article

Assessing the Risk of APOE - ϵ 4 on Alzheimer’s Disease Using Bayesian Additive Regression Trees

Author

Listed:
  • Yifan Xia

    (Institute of Medical Technology, Peking University, Beijing 100191, China)

  • Baosheng Liang

    (Department of Biostatistics, School of Public Health, Peking University, Beijing 100191, China)

Abstract

Alzheimer’s disease (AD) affects about a tenth of the population aged over 65 and nearly half of those over 85, and the number of AD patients continues to grow. Several studies have shown that the ϵ 4 variant of the apolipoprotein E ( A P O E ) gene is potentially associated with an increased risk of AD. In this study, we aimed to investigate the causal effect of A P O E - ϵ 4 on Alzheimer’s disease under the potential outcome framework and evaluate the individualized risk of disease onset for A P O E - ϵ 4 carriers. A total of 1705 Hispanic individuals from the Washington Heights-Inwood Columbia Aging Project (WHICAP) were included in this study, comprising 453 A P O E - ϵ 4 carriers and 1252 non-carriers. Among them, 265 subjects had developed AD (23.2%). The non-parametric Bayesian additive regression trees (BART) approach was applied to model the individualized causal effects of A P O E - ϵ 4 on disease onset in the presence of right-censored outcomes. The heterogeneous risk of A P O E - ϵ 4 on AD was examined through the individualized posterior survival probability and posterior causal effects. The results showed that, on average, patients carrying A P O E - ϵ 4 were 0.968 years younger at onset than those with non-carrying status, and the disease risk associated with A P O E - ϵ 4 carrying status was 3.9 % higher than that for non-carrying status; however, it should be noted that neither result was statistically significant. The posterior causal effects of A P O E - ϵ 4 for individualized subjects indicate that 14.41% of carriers presented strong evidence of AD risk and approximately 38.65% presented mild evidence, while around 13.71% of non-carriers presented strong evidence of AD risk and 40.89% presented mild evidence. Furthermore, 79.26% of carriers exhibited a posterior probability of disease risk greater than 0.5. In conclusion, no significant causal effect of the A P O E - ϵ 4 gene on AD was observed at the population level, but strong evidence of AD risk was identified in a sub-group of A P O E - ϵ 4 carriers.

Suggested Citation

  • Yifan Xia & Baosheng Liang, 2023. "Assessing the Risk of APOE - ϵ 4 on Alzheimer’s Disease Using Bayesian Additive Regression Trees," Mathematics, MDPI, vol. 11(13), pages 1-17, July.
  • Handle: RePEc:gam:jmathe:v:11:y:2023:i:13:p:3019-:d:1188780
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2227-7390/11/13/3019/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/2227-7390/11/13/3019/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jmathe:v:11:y:2023:i:13:p:3019-:d:1188780. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.